Aemetis Inc. (NASDAQ:AMTX) – FBR & Co increased their FY2016 earnings per share estimates for shares of Aemetis in a research report issued on Monday. FBR & Co analyst C. Driscoll now forecasts that the brokerage will post earnings per share of ($0.91) for the year, up from their previous estimate of ($1.04). FBR & Co currently has a “Hold” rating and a $2.00 target price on the stock. FBR & Co also issued estimates for Aemetis’ Q4 2016 earnings at ($0.18) EPS, Q1 2017 earnings at ($0.19) EPS, Q2 2017 earnings at ($0.20) EPS, Q3 2017 earnings at ($0.17) EPS, Q4 2017 earnings at ($0.17) EPS and FY2017 earnings at ($0.72) EPS.

Separately, Zacks Investment Research raised shares of Aemetis from a “hold” rating to a “buy” rating and set a $2.00 price objective for the company in a research note on Wednesday.

Earnings History and Estimates for Aemetis (NASDAQ:AMTX)

Aemetis (NASDAQ:AMTX) opened at 1.82 on Wednesday. Aemetis has a 52-week low of $1.01 and a 52-week high of $3.05. The stock has a 50 day moving average price of $1.63 and a 200 day moving average price of $1.88. The company’s market capitalization is $36.14 million.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Monday, November 14th. The company reported ($0.21) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.27) by $0.06.

A hedge fund recently raised its stake in Aemetis stock. Geneva Advisors LLC increased its position in shares of Aemetis Inc. (NASDAQ:AMTX) by 4.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,453,131 shares of the company’s stock after buying an additional 68,460 shares during the period. Geneva Advisors LLC owned approximately 7.32% of Aemetis worth $1,569,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 18.57% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this article can be read at

About Aemetis

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

5 Day Chart for NASDAQ:AMTX

Receive News & Stock Ratings for Aemetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc. and related stocks with our FREE daily email newsletter.